RESUMEN
The Abelson murine leukemia virus (Ab-MLV), like other retroviruses that contain v-onc genes, arose following a recombination event between a replicating retrovirus and a cellular oncogene. Although experimentally validated models have been presented to address the mechanism by which oncogene capture occurs, very little is known about the events that influence emerging viruses following the recombination event that incorporates the cellular sequences. One feature that may play a role is the genetic makeup of the host in which the virus arises; a number of host genes, including oncogenes and tumor suppressor genes, have been shown to affect the pathogenesis of many murine leukemia viruses. To examine how a host gene might affect an emerging v-onc gene-containing retrovirus, we studied the weakly oncogenic Ab-MLV-P90A strain, a mutant that generates highly oncogenic variants in vivo, and compared the viral populations in normal mice and mice lacking the p53 tumor suppressor gene. While variants arose in both p53+/+ and p53-/- tumors, the samples from the wild-type animals contained a more diverse virus population. Differences in virus population diversity were not observed when wild-type and null animals were infected with a highly oncogenic wild-type strain of Ab-MLV. These results indicate that p53, and presumably other host genes, affects the selective forces that operate on virus populations in vivo and likely influences the evolution of oncogenic retroviruses such as Ab-MLV.
Asunto(s)
Virus de la Leucemia Murina de Abelson/genética , Virus de la Leucemia Murina de Abelson/patogenicidad , Genes p53 , Leucemia Experimental/genética , Leucemia Experimental/virología , Infecciones por Retroviridae/genética , Infecciones por Retroviridae/virología , Infecciones Tumorales por Virus/genética , Infecciones Tumorales por Virus/virología , Virus de la Leucemia Murina de Abelson/aislamiento & purificación , Animales , Secuencia de Bases , ADN Viral/genética , Femenino , Variación Genética , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Mutación , Virulencia/genética , Integración Viral/genéticaRESUMEN
The detection of specific RNA species in wax-embedded tissue sections using the polymerase chain reaction (PCR) means that gene expression can be studied and RNA viruses detected in stored histological tissue samples. This technique potentially allows the distribution of gene expression and viral replication to be studied in finely subdivided tissues. A technique is presented that has been used successfully to detect short RNA target sequences (130-420 bases) from proto-oncogene Abelson, human enteroviruses, and the sheep retrovirus Maedi-Visna virus using RNA PCR in single wax sections (20-30 microns). Various tissues were used which had not been deliberately prepared for this purpose. In a simple procedure hot xylene dewaxing is followed by acid phenol extraction of RNA and RNA PCR.
Asunto(s)
Reacción en Cadena de la Polimerasa/métodos , Virus ARN/aislamiento & purificación , ARN Viral/análisis , Virus de la Leucemia Murina de Abelson/aislamiento & purificación , Animales , Secuencia de Bases , Enterovirus/aislamiento & purificación , Humanos , Datos de Secuencia Molecular , Adhesión en Parafina , Proto-Oncogenes Mas , Proto-Oncogenes , Ovinos , Virología/métodos , Virus Visna-Maedi/aislamiento & purificación , XilenosRESUMEN
We recently showed that hemopoietic stem cells expressing the v-abl oncogene can cause leukemia when injected into lethally irradiated recipient mice. Progenitor cells expressing v-abl did not significantly contribute to disease development, and the leukemia was monoclonal in origin. By serially transplanting v-abl-transduced hemopoietic stem cells into normal, nonirradiated syngeneic recipients, we showed that multiple stem-cell clones do exist in some recipients. These cells fluctuated as normal stem cells do and could home to normal bone marrow. Based on the time course of disease, the recipients developed either an acute or a chronic phase of disorder. All recipients with the acute disease had stem-cell clones with random Abelson murine leukemia virus integration sites. All recipients with the chronic disorder had a specific Abelson murine leukemia virus integration site. We believe this abl-specific integration site, termed ASI, is important in abl-mediated stem-cell leukemogenesis.
Asunto(s)
Virus de la Leucemia Murina de Abelson/genética , Células Madre Hematopoyéticas/microbiología , Leucemia Experimental/microbiología , Trastornos Mieloproliferativos/microbiología , Virus de la Leucemia Murina de Abelson/aislamiento & purificación , Virus de la Leucemia Murina de Abelson/patogenicidad , Animales , Southern Blotting , ADN Viral/genética , ADN Viral/aislamiento & purificación , Genes abl , Trasplante de Células Madre Hematopoyéticas , Leucemia Experimental/genética , Hígado/embriología , Hígado/microbiología , Ratones , Ratones Endogámicos BALB C , Trastornos Mieloproliferativos/genética , Mapeo Restrictivo , Irradiación Corporal TotalRESUMEN
v-abl, the oncogene transduced by Abelson murine leukemia virus, was first characterized by its ability to transform lymphoid cells. bcr-abl, the oncogene formed by a t(9;22) translocation thought to occur in human hematopoietic stem cells, is detectable in almost all cases of chronic myelogenous leukemia (CML), a malignancy of granulocytic cells. bcr-abl also causes a CML-like syndrome in mice whose bone-marrow cells are infected with a retrovirus transducing the gene. More recent reports have suggested that v-abl can, however, cause a disease similar to CML. We demonstrate here that v-abl, when transduced in a helper virus-containing system, causes disease similar to, but distinct from, the CML-like syndrome induced by bcr-abl. Animals whose bone marrow has been infected by v-abl virus develop modest splenomegaly, marked granulocytosis, and malignant disease of several hematopoietic cell types. Unlike animals with CML-like disease resulting from bcr-abl, the polymorphonuclear leukocytes from animals infected with a v-abl construct do not contain the v-abl provirus at a significant frequency. Histopathologic analysis also shows significant differences between the diseases caused by v-abl and bcr-abl.
Asunto(s)
Proteínas de Fusión bcr-abl/genética , Genes abl , Células Madre Hematopoyéticas/patología , Leucemia Experimental/genética , Oncogenes , Virus de la Leucemia Murina de Abelson/genética , Virus de la Leucemia Murina de Abelson/aislamiento & purificación , Animales , Médula Ósea/patología , Línea Celular , Leucemia Experimental/microbiología , Leucemia Experimental/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Provirus/genética , Provirus/aislamiento & purificación , Bazo/patologíaRESUMEN
Activation of the abl gene and its involvement in human leukemia is one of the most thoroughly characterized examples of the structural alterations of chromosomes associated with the conversion of a normal cell into a cancer cell. The abl oncogene as first identified on the Abelson murine leukemia virus (A-MuLV). Activation of the viral oncogene is associated, in part, with the truncation of the gene at its 5' end. As in studies with other retroviruses, results with A-MuLV presaged the mechanism of activation by abl in naturally occurring human malignancies. Thus, chronic myelogenous leukemia (CML) is consistently associated with a translocation of a piece of chromosome 9 onto chromosome 22 creating what is known as the Philadelphia chromosome (Ph1). The result of this translocation is the truncation of the 5' end of the cellular abl gene, which is located at the breakpoint of chromosome 9. The function of the abl gene product is poorly understood but is thought to participate in an, as yet, undefined pathway of growth control signals, which originate outside the cell, and traverse through the cell into its nucleus. The loss of the gene product's N-terminal amino acid sequences brought about by the truncation of the 5' portion of the gene is consistent with the hypothesis that the protein's growth-controlling activity is deregulated by the structural alterations which occur in the cancer cells. The abl gene and CML serve as a paradigm of the mechanism of activation of proto-oncogenes by chromosomal alterations. The case of CML and the Ph1 chromosome illustrates the findings we might expect as other chromosomal abnormalities are characterized at the molecular level.